Scott Stromatt, EVP, Clinical Development & Reg Affair at CELL THERAPEUTICS INC (CTIC), sold 625 shares at $3.87 ($2K) on 2007-08-31, disclosed to the SEC on 2007-09-04.
Scheduled sale ($2k) by EVP, Clinical Development & Reg Affair under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| CTIC | SELL | 2006-09-01 | $4K | — | Filing → |
| CTIC | SELL | 2006-06-22 | $28K | — | Filing → |